Home
Parallel Trade

SAE Media Group is proud to present their 7th annual Pharmaceutical Parallel Trade Conference . Parallel trade 2013 aims to provide you with the latest developments from industry experts across a range of sectors. Parallel trade has shown to be a rapidly expanding – stay on top of the latest regulations and strategies of both traders and those who try who can take advantage of open trading.

The growth of parallel trade can often divide opinions. Free movements of goods across the EU has meant better access to cheaper drugs to many patients. It has however opened up an increasingly bigger problem facing healthcare professionals in counterfeit drugs, something that can often lead to huge losses in revenues for pharmaceutical companies, and thus effect future investment in R&D.

Parallel trade 2013 aims to show you both sides of the argument between trading of medicines – taking industry experts in patient safety, IP law, counterfeiting, and parallel traders.

FEATURED SPEAKERS

Doina Ionescu

Doina Ionescu

Managing Director, Merck
Eric Noehrenberg

Eric Noehrenberg

Director, Public Affairs for Market Access, Shire Pharmaceuticals
Tomasz Dzitko

Tomasz Dzitko

Founder and CEO , Delfarma

Anna Rita Bennato

Post Doc Research Fellow, University Of East Anglia
Anna Rita Bennato

Antonio Mendonca Alves

CEO, MD Pharma SA
Antonio Mendonca Alves

Axel Schulz

Partner, White & Case LLP
Axel Schulz

Christopher Stothers

Partner, Arnold and Porter
Christopher Stothers

Dermot Glynn

Chairman, Europe Economics
Dermot Glynn

Doina Ionescu

Managing Director, Merck
Doina Ionescu

Eric Noehrenberg

Director, Public Affairs for Market Access, Shire Pharmaceuticals
Eric Noehrenberg

Fabrizio Gianfrate

Professor of Health Economics, University of Ferrara
Fabrizio Gianfrate

Heinz Kobelt

Director European Affairs, European Association of Euro-Pharmaceutical Companies
Heinz Kobelt

Janice Haigh

Practice Leader, Market Access, Europe, Quintiles Consulting
Janice Haigh

Janice Kite

Traceability Director Healthcare, GS1 Global Office
Janice Kite

Jim Thomson

Chair, European Alliance for Access to Safe Medicines
Jim Thomson

Mike Isles

Executive Director, European Alliance for Access to Safe Medicines
Mike Isles

Nosh Lentin

Mangaing Director, Operations & Supply Mngt. Ltd.
Nosh Lentin

Peter Bogaert

Partner, Food & Drug Law, Covington & Burling Belgium
Peter Bogaert

Tomasz Dzitko

Founder and CEO , Delfarma
Tomasz Dzitko

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

clock

9:10

Capturing Team objectives & status

clock

9:50

Brainstorming ideas / strategies

clock

10:30

Morning Coffee

clock

11:00

Narrowing down ideas into feasible steps

clock

11:40

Developing a Time Line for execution

clock

12:20

Close of workshop

clock

13:30

Registration & Coffee

clock

14:00

Welcome & Introductions

clock

14:10

Background to Parallel Trade

clock

14:30

Parallel Trade Management Options

clock

14:50

Introductions to Supply Chain Management

clock

15:20

Afternoon Refreshments

clock

15:50

Critical Success Factors

clock

16:20

Review of Tactical Details

clock

17:00

Dealing with Challenges from Wholesalers and Pharmacists

clock

17:30

Q&A

clock

18:00

Close of Workshop

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Eric Noehrenberg

Eric Noehrenberg , Director, Public Affairs for Market Access, Shire Pharmaceuticals

clock

9:10

Impact of parallel trade on patients

Eric Noehrenberg

Eric Noehrenberg , Director, Public Affairs for Market Access, Shire Pharmaceuticals

  • Do patients benefit from parallel trade
  • Safety concerns
  • Quality issues
  • Public health impact
  • clock

    9:50

    GS1 Standards: Foundational to the EU supply chain

    Janice Kite

    Janice Kite, Traceability Director Healthcare, GS1 Global Office

  • It’s not just EU!
  • GS1 Standards for Healthcare: Process and Technical Standards
  • The move to implementation
  • How GS1 Standards can assist in the fight against counterfeit, improving patient safety and in compliance to the Directive for Falsified Medicines directive

     

  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Creating a supply chain model for demand management and controlling service provision by country / affiliate

    Nosh Lentin

    Nosh Lentin, Mangaing Director, Operations & Supply Mngt. Ltd.

  • Segmenting customer demand at country level
  • Obtaining data to monitor weekly demand
  • Setting gates for manging level of demand
  • Execute and monitoring performance
  • clock

    11:40

    Taking patient safety to a next level: The stakeholder driven European Medicines Verification System ESM

    Heinz Kobelt

    Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceutical Companies

  • Patient safety in parallel distribution today
  • Next step: ESM-stakeholder approach for implementing the falsified medicines directive
  • ESM - Technical features and governance model
  • Connecting in the real world: Integrating manufacturers, wholesalers, pharmacies and parallel distributors
  • The EMS as a cost effective way to ensure a high level of patient safety
  • clock

    12:20

    Networking Lunch

    clock

    13:40

    Life after the Falsified Medicines Directive - opportunities and threats

    Mike Isles

    Mike Isles, Executive Director, European Alliance for Access to Safe Medicines

  • We live in the 21st centuary - let's embrace that
  • Where will the counterfeiter peddle his wares now?
  • How can we ensure that patients are protected and truly benefit from the FMD
  • clock

    14:20

    Parallel trade and pharmaceutical company dynamics

    Doina Ionescu

    Doina Ionescu, Managing Director, Merck

  • Facts and figures
  • Local global company implications
  • Local environment issues
  • clock

    15:00

    Afternoon Tea

    clock

    15:30

    Impact and response of pharmaceutical industry to parallel trade

    Fabrizio Gianfrate

    Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara

  • Impact on pharmaceutical industry R&D investments
  • Strategies of pharmaceutical industries to contrast PT
  • Potential EU and local countries regulatory scenarios
  • clock

    16:20

    Managing parallel trade – practical guidance for manufacturers

    Janice Haigh

    Janice Haigh, Practice Leader, Market Access, Europe, Quintiles Consulting

  • What is the impact of parallel trade on pharmaceutical manufacturers?
  • What are the available strategies for managing parallel trade?
  • What are the legal and practical challenges?
  • How should we address these?
  • clock

    17:00

    Chairman’s Closing Remarks and Close of Day One

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Eric Noehrenberg

    Eric Noehrenberg , Director, Public Affairs for Market Access, Shire Pharmaceuticals

    clock

    9:10

    Parallel Import in Poland - the third legitimate market player

    Tomasz Dzitko

    Tomasz Dzitko, Founder and CEO , Delfarma

  • The economies of parallel import
  • Initiatives of parallel importers in the context of falsified medicines directive
  • Optimisation of the supply chain
  • A way forward
  • clock

    9:50

    Parallel trade from a competition law perspective – an update

    Axel Schulz

    Axel Schulz, Partner, White & Case LLP

  • Update on relevant case-law
  • Restructuring of the greek market
  • New interest by the European Commission
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Intellectual Property Update

    Christopher Stothers

    Christopher Stothers, Partner, Arnold and Porter

  • Using the Specific Mechanism to prevent parallel imports from “new” Member States
  • Using Border Controls to stop parallel imports
  • Impact of developments in other fields of parallel trade
  • clock

    11:40

    Pharmaceutical innovation and parallel trade

    Anna Rita Bennato

    Anna Rita Bennato, Post Doc Research Fellow, University Of East Anglia

  • Parallel trade in the pharmaceutical sector
  • Interaction between government regulation policies and parallel trade
  • Focus on policy in the pharmaceutical sector
  • Patent holders decisions under a regime of parallel trade
  • clock

    12:20

    Networking Lunch

    clock

    13:50

    The impact of the Falsified Medicines Directive on parallel imports

    Peter Bogaert

    Peter Bogaert, Partner, Food & Drug Law, Covington & Burling Belgium

  • Safety features and their impact
  • Specific aspects of repackaging
  • Regulatory controls
  • clock

    14:30

    Effects of parallel trade on affordable access to medicines

    Dermot Glynn

    Dermot Glynn, Chairman, Europe Economics

  • The eurocrisis and parallel trade
  • How to ensure safe supplies of medicines for hard-hit countries
  • Optimal pricing strategies within the EU
  • clock

    15:10

    Afternoon Tea

    clock

    15:40

    Why parallel trade exists? - A traders point of view

    Antonio Mendonca Alves

    Antonio Mendonca Alves, CEO, MD Pharma SA

  • Benefits to consumers
  • general access to medicines within the EU
  • Benefits of a single EU market to wholesaling strategies
  • patient and government savings in the importing contries
  • Profits and tax revinues in exporting countries
  • clock

    16:20

    PANEL DISCUSSION - The future of parallel trade

    Eric Noehrenberg

    Eric Noehrenberg , Director, Public Affairs for Market Access, Shire Pharmaceuticals

    Tomasz Dzitko

    Tomasz Dzitko, Founder and CEO , Delfarma

    Peter Bogaert

    Peter Bogaert, Partner, Food & Drug Law, Covington & Burling Belgium

    Jim Thomson

    Jim Thomson, Chair, European Alliance for Access to Safe Medicines

    clock

    17:00

    Chairman’s Closing Remarks and Close of Day Two


    Chairman
    Europe Economics
    Executive Director
    European Alliance for Access to Safe Medicines
    Practice Leader, Market Access, Europe
    Quintiles Consulting
    Managing Director
    Merck
    Director, Public Affairs for Market Access
    Shire Pharmaceuticals
    Post Doc Research Fellow
    University Of East Anglia
    Mangaing Director
    Operations & Supply Mngt. Ltd.
    Director European Affairs
    European Association of Euro-Pharmaceutical Companies
    Partner
    White & Case LLP
    Traceability Director Healthcare
    GS1 Global Office
    Chair
    European Alliance for Access to Safe Medicines
    CEO
    MD Pharma SA
    Partner, Food & Drug Law
    Covington & Burling Belgium
    Partner
    Arnold and Porter
    Founder and CEO
    Delfarma
    Professor of Health Economics
    University of Ferrara

    Workshops

    Parallel Trade in Life Sciences

    Parallel Trade in Life Sciences

    Copthorne Tara Hotel
    5 February 2013
    London, United Kingdom

    Parallel Trade Management Strategies

    Parallel Trade Management Strategies

    Copthorne Tara Hotel
    5 February 2013
    London, United Kingdom

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.